Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer

Cancer Journal

Volumn 10, Issue 4, 2004, Pages 243-250

  Larson, Steven M ^a,b   Schoder, Heiko ^a,b   Yeung, Henry ^a,b  

^a Memorial Sloan Kettering Cancer Center ^*

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Computed tomography; PET FDG imaging; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; ESOPHAGUS CANCER; HUMAN; METASTASIS; PATIENT CARE; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR LOCALIZATION; COLORECTAL TUMOR; DISEASE COURSE; ESOPHAGUS TUMOR; IMAGE PROCESSING; IMAGE QUALITY; REVIEW; SCINTISCANNING;

COLORECTAL NEOPLASMS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 16644383003     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200407000-00005     Document Type: Article

References (32)

1. Nutt R. 1999 ICP Distinguished Scientist Award. The history of positron emission tomography. Mol Imaging Biol 2002;4:11-26.
2. Warburg O. On the origin of cancer cells. Science 1956;123:309-314.
3. Townsend DW, Beyer T, Meltzer CC, et al. The ECAT ART scanner for positron emission tomography. 1. Improvements in performance characteristics. Clin Positron Imaging 1999;2:5-15.
4. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369-1379.
5. Schoder H, Erdi YE, Larson SM, Yeung HW. PET/CT: a new imaging technology in nuclear medicine. Eur J Nucl Med Mol Imaging 2003;30:1419-1437.
6. Larson SM, Erdi Y, Akhurst T et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging 1999;2:159-171.
7. Downey RJ, Akhurst T, Ilson D et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 2003;21:428-432.
8. Flanagan FL, Dehdashti F, Siegel BA et al. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 1997;168:417-424.
9. Luketich JD, Schauer PR, Meltzer CC et al. Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 1997;64:765-769.
10. Yeung HW, Macapinlac HA, Mazumdar M et al. FDG-PET in esophageal cancer. Incremental value over computed tomography. Clin Positron Imaging 1999;2:255-260.
11. Flamen P, Lerut A, Van Cutsem E et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000;18:3202-3210.
12. Meltzer CC, Luketich JD, Friedman D et al. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography. Clin Nucl Med 2000;25:882-887.
13. Yoon YC, Lee KS, Shim YM et al. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology 2003;227:764-770
14. Brucher BL, Weber W, Bauer M et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg. 2001;233:300-309.
15. Rizk NP, Downey RJ. Resection of pulmonary metastases from colorectal cancer. Semin Thorac Cardiovasc Surg 2002;14:29-34.
16. Fong Y. Hepatic colorectal metastasis: current surgical therapy, selection criteria for hepatectomy, and role for adjuvant therapy. Adv Surg 2000;34:351-381.
17. Weber SM, Jarnagin WR, De Matteo RP et al. Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 2000;7:643-650.
18. Kemeny N, Jarnagin W, Gonen M et al. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol 2003;21:3303-3309.
19. Gonen M, Hummer A, Zervoudakis A et al. Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. J Clin Oncol 2003;21:406-412.
20. Pandit-Taskar N. AJR Am J Roentgenol 2004, in press.
21. Fong Y, Saldinger PF, Akhurst T et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 1999;178:282-287.
22. Moore HG, Akhurst T, Larson SM et al. A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg 2003;197:22-28.
23. Coleman RE. Clinical PET in oncology. Clin Positron Imaging 1998;1:15-30.
24. Halkar RK, Toro JR, Lim EH et al. Role of FDG-PET in the preoperative evaluation of surgical resection of hepatic metastases from colorectal cancer. Clin Positron Imaging 1999;2:335.
25. Kinkel K, Lu Y, Both M et al. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002;224:748-756.
26. Lonneux M, Reffad AM, Detry R et al. FDG-PET improves the staging and selection of patients with recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 2002;29:915-921.
27. Simo M, Lomena F, Setoain J et al. FDG-PET improves the management of patients with suspected recurrence of colorectal cancer. Nucl Med Commun 2002;23:975-982.
28. Dietlein M, Weber W, Schwaiger M, Schicha H. [18F]-Fluorodeoxyglucose positron emission tomography in restaging of colorectal cancer]. Nuklearmedizin 2003;42:145-156.
29. Miller E, Lerman H, Gutman M et al. The clinical impact of camera-based positron emission tomography imaging in patients with recurrent colorectal cancer. Invest Radiol 2004;39:8-12.
30. Tutt AN, Plunkett TA, Barrington SF, Leslie MD. The role of positron emission tomography in the management of colorectal cancer. Colorectal Dis 2004;6:2-9.
31. Cohade C, Osman M, Leal J, Wahl RL. Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003;44:1797-1803.
32. Kantorova I, Lipska L, Belohlavek O et al. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med 2003;44:1784-1788.